Altered TNF-Alpha, Glucose, Insulin and Amino Acids in Islets Langerhans Cultured in a Microgravity Model System by Leeper-Woodford, Sandra K. et al.
Source of Acquisition
NASA Johnson Space Center
Manuscript: E-632-9-R
REVISED SUBMISSION
J^
CCD?^^':
ALTERED TNF-ALPHA, GLUCOSE, INSULIN AND AMINO ACIDS IN ISLETS OF
LANGERHANS CULTURED IN A MICROGRAVITY MODEL SYSTEM
Brian W. Tobin,' Sandra K. Leeper-Woodford'- Brian B. Hashemi, 3 Scott M. Smith,' and
Clarence F. Sams5
'Diabetes Research Laboratory, Program in Nutrition and Biochemistry, zProgram in Physiology,
Division of Basic Medical Sciences, Mercer University School of Medicine, Macon, Georgia
31207, 3National Space Biomedical Research Institute, One Baylor Plaza, NA-425, Houston
77030, 'Nutritional Biochemistry Laboratory, 'Laboratory for Human Immune Function and
Signal Transduction, Life Sciences Research Laboratories, National Aeronautics and Space
Administration Lyndon B. Johnson Space Center, Houston, Texas 77058.
https://ntrs.nasa.gov/search.jsp?R=20100033769 2019-08-30T11:52:38+00:00Z
Manuscript: E-632-9-R
Abstract
The present studies were designed to determine effects of a microgravity model system
upon lipopolysaccharide (LPS) stimulated tumor necrosis factor alpha (TNF-alpha) activity and
indices of insulin and fuel homeostasis of pancreatic islets of Langerhans. Islets (1726±1 17, 150
u IEU) from Wistar Furth rats were treated as: 1) HARV (High Aspect Ratio Vessel cell culture)
, 2) HARV plus LPS, 3) static culture, 4) static culture plus LPS. TNF-alpha (L929 cytotoxicity
assay) was significantly increased ill 	 HARV and static cultures, yet the increase was
more pronounced in the static culture group (p<0.05). A decrease in insulin concentration was
demonstrated in the LPS stimulated HARV culture (p<0.05). We observed a greater glucose
concentration and increased disappearance of arginine in islets cultured in HARVs. While
nitrogenous compound analysis indicated a ubiquitous reliance upon glutamine in all
experimental groups, arginine was converted to ornithine at a two-fold greater rate in the islets
cultured in the HARV microgravity model system (p<0.05). These studies demonstrate
alterations in LPS induced TNF-alpha production of pancreatic islets of Langerhans, favoring a
lesser TNF activity in the HARV. These alterations in fuel homeostasis may be promulgated by
gravity averaged cell culture methods or by three dimensional cell assembly.
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INTRODUCTION
Factors which modulate glucose tolerance and hyperglycemia in diabetes, and it's related
syndromes include pancreatic islet insulin secretory function, hepatic and peripheral insulin
sensitivity, and glucose effectiveness (7, 42, 16). An intriguing candidate peptide which has
recently been implicated in the glucose intolerance of diabetes and obesity, is the cytokine tumor
necrosis factor-alpha (TNF-alpha). TNF-alpha is a potent modulator of insulin sensitivity in
adipocytes (1, 13). Increased TNF-alpha induces peripheral insulin resistance which can
decrease glucose utilization. While it was once believed that macrophages and adipocytes were
the primary sites of TNF-alpha production, we have recently demonstrated that purified
pancreatic islets of Langerhans are a potent source of TNF-alpha (20). These observations
suggest a putative islet-linked site of action for TNF-alpha in glucose intolerance.
Prolonged bedrest has long been utilized as a paradigm for insulin resistance and glucose
intolerance; it also resembles metabolic alterations observed in microgravity (29). Human
bedrest studies (21, 22) demonstrate increased peripheral tissue insulin resistance and reduced
glucose tolerance. Similarly, post-flight investigations of cosmonauts (12) after free-fall orbit
demonstrate increased plasma glucose and decreased glucose tolerance. Other space-flight
investigations iliustrate aitered C-peptide excretion (33) and insulin resistance (R) during earth
orbit. These observations and others (24) suggest that bedrest and in-flight experiments support
-	 similar-ohanges to that observed in the glucose intolerance .of.pre-diabetes, aging, physical
inactivity or obesity.
A series of in vitro studies illustrate altered immune cell cytokine activity in microgravity
which may favor increased insulin resistance via altered TNF-alpha release. The SL-3 mission
demonstrated that immune responses may be altered by space flight (32). On STS-56, MC3T3-
E 1 osteoblasts activated in microgravity utilized less glucose and had reduced prostaglandin E 2, a
proposed regulator of cytokine production (15). As little as eight seconds of microgravity has
been demonstrated to alter macrophage responses (2). Lipopolysaccharide (LPS) activated
macrophages secrete more IL-1 and TNF-alpha when stimulated in microgravity than on earth
(6). These space flight studies may provide insight into a mechanistic link between immune
modulations and glucose tolerance. However, serious questions remain as to which . observations
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are due to stressors of lift-off and re-entry, and which are true microgravity effects.
While there is disagreement as to whether ground-based paradigms truly simulate
microgravity (38), certain cell culture systems provide a model system for investigating altered
gravity effects. One such microgravity model system is the High Aspect Ratio Vessel (HARV),
developed at the Johnson Space Center. The HARV is a self contained horizontally rotating cell.
culture system that allows for diffusion of oxygen and carbon dioxide across a semi permeable
membrane. The HARV demonstrates a very low shear stress (0.5 dynes/cm-) for one or two mm
cellular aggregates (38). It has a time- averaged gravity vector of 10 -2 g (31) as compared to that
of near-earth free-fall orbit which is 10' - 10 -6 g. Thus, the HARV is a useful paradigm for
studying cellular physiology in a ground based, cell culture system, which demonstrates both low
shear stress and a gravity averaged free-fall paradigm.
The present studies were designed to determined the main and interactive effects of
microgravity and addition of LPS on TNF-a activity, insulin secretion and glucose
concentrations in cultured islets of Langerhans. An additional aim was to determine alterations
in amino acid and nitrogenous compound utilization as an explanation for altered glucose
concentrations in the microgravity model system.
SUBJECTS AND METHODS
-	 Animal_Care.,
Male Wistar Furth rats (Harlan Sprague-Dawley, Houston TX, Indianapolis, IN) were
_.	 obtained at 9-10 weeks of age, approximately 220 grams body weight, and housed in shoebox
cages (n=3 / cage) with cellulose bedding. Animals were maintained on a twelve hour light/dark
cycle (lights on 0700 hr) and had access to food and water ad libitum. All procedures were
carried out in accordance with the guidelines of the National Institutes of Health and were
f;
	
	 approved by the NASA-Johnson Space Center and Mercer University Institutional Animal Care
and Use Committees.
Study Design
There were two studies carried out in these experiments (Fig la): In Study A, we
-2-
Manuscript: E-632-9-R
contrasted the HARV cell culture technique vs. the static plate paradigm. In Study B the
previous groups were further subdivided into LPS-stimulated and non-stimulated treatment
groups. This experimental design allowed us to differentiate the independent effects of the cell
culture method (HARV vs. PLATE) under basal conditions upon TNF-alpha activity, glucose,
insulin, lactate and amino acids (Study A), and, determine if interactions of LPS administration
and the cell culture method were operative in regulating glucose and insulin levels (Study B).
Pancreatectomv and Islet Isolation: Day 1. 2
All animals were acclimatized to the laboratory for one to two weeks prior to beginning
experiments. We removed food from the cages of donor male Wistar Furth rats at approximately
1800 h: at 0800 h the following morning (day 1, Fig. la) the rats were anesthetized with 55
mg/kg sodium pentobarbital i.p., and pancreatectomized. Animals were exsanguinated under
surgical anesthesia following pancreatectomy. Islets were isolated using established methods
(3), with modifications previously described (11). Purified islets were hand picked to obtain
approximately 1700 islets per treatment group, using 25x magnification with a green illuminated
background and white fiber optic side illumination.
Static Culture of Islets Following Islet Isolation: Day 1, 2
FFe hl-yd*solated islets -of.Langerhans,:vyere,placed into ^Qdium-199 (with additional 100
U/ml penicillin, 100 µg/ml streptomycin, 10% fetal bovine serum, 25 mmoles/1 Hepes buffer,
0.68 mmoles/1 L-glutamine) as previously described (11). Islets were isolated over a two day
period. The islets from two rats each (6 rats per day of isolation), were placed into 6-well
polystyrene culture plates with 10 ml Medium-199 per well (approx. 1200 islets). Islets were
introduced into static culture at approximately 1700 hrs. Islets remained on static culture for 24 -
48 hours prior to being aliquoted into HARV cultures for experiments
HARV Cell Culture Techniques for Pancreatic Islets: Day 3, 4
Islets were aspirated from culture plates and cells were transferred into one 50 ml conical
vial and brought to 40 cc with M-199. Islets from all pancreatic isolations were mixed, then
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aliquoted into 4, 15 ml conical vials and centrifuged at 1000 rpm. The vials were vortexed, and
aliquots of 100 ul (3x) were removed for determination of islet diameter, which was estimated
according to standards established by Ricordi and colleagues (30). A one ml sample was
obtained and designated as 0 HRS (Study A) and frozen at -70° C.
Islets (1726±1 17, 150 u IEU) were aliquoted into 2, 10-m1 High Aspect Ratio Vessels
(HARV, Synthecon, Houston) and into culture plate wells and were placed into a 5% CO 2, 95%
humidified, 37° C incubator. The initial HARV speed was set at approximately 12 revolutions
per minute. All bubbles were carefully removed from the HARVS prior to initiating revolutions.
Preparation for LPS Stimulation: Dav 5
Following 48 hours of HARV or static culture, 1 ml of islet media was aliquoted for
analvsis and designated as 48 HRS (Study A). Both HARV and static cultures had 5 ml freshly
prepared Medium-199 added to bring the total volume to 10 ml. All subsequent samples were
taken by isovolumetric techniques. In the HARV, this was accomplished by infusing 300 uL of
cold (4° C) Medium-199 into the bottom port of a vertical, stationary HARV while removing 300
uL of sample from the upper port. A similar technique was used in static cultures to assure equal
treatment perturbations.
LPS Stimulation; Samples for TNF, Insulin, Glucose, Lactate: Day 5, 6 -
Prior to LPS addition, a 300 uL sample was removed from all treatments and designated
as 0 HRS post LPS stimulation. At time zero, 100 uL of a 100 pg/ml LPS (EColi 026:B6,
Sigma, St. Louis) dissolved in Medium-199 were added to HARVs and static cultures. Islet
medium samples were obtained (300 uL) for TNF, glucose, insulin, and lactate analysis at 3, 6,
12, 24, and 48 hours post LPS stimulation. The samples were placed immediately into 1.8 ml
cryovials and stored at -70° C for subsequent analyses.
Islet and Cell Image Analysis: Days 3, 5 (cohort group)
Islets were obtained from HARV and static cultures for image analysis by phase contrast
and confocal microscopy. Representative images islets of Langerhans from the initial static
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culture period (day 3), and islet cells cultured in HARVs (day 5) were obtained on a Hund
Willovert S inverted microscope equipped with phase contrast optics, a green filter, and white
fiber optic side illumination. Islets were maintained in culture medium and images were
acquired using a Cannon EOS IN 35mm camera and a 40x air objective.
Sample Anal
Tumor Necrosis Factor Assay: The L929 mouse fibroblast assay, as previously described
(18, 19, 20), was used to measure islet medium TNF activity. Briefly, L929 cells were grown to
confluence overnight in 96 well culture plates; Actinomycin-D (5 µg/ml; Merck Sharp & Dolune,
Weston, PA) was added to each well and serial dilutions of experimental islet medium were
added to duplicate L929 wells. Following incubation, adherent L929 cells were stained with
0.5% crystal violet, optical density of each well was spectrophotometrically measured and %
cytotoxicity of L929 cells was determined (27). TNF activity was then converted to Units/ml
(U/ml); one unit of TNF activity was defined as equal to 50% L929 cytotoxicity in the
appropriate dilution of islet medium. Dose-response inhibition of TNF activity using rat-specific
TNF-alpha antibodies (Endogen Inc., Boston, MA) were performed on islet medium samples to
confirm that L929 cytotoxicity was due to TNF-alpha activity.
Insulin Analysis: Islet medium was diluted 1:500 in Medium-199, and insulin was
determined by..competitive binding radio 1mmunoassay(LI _ . St. _Charles, MO with antibodies
-	
).
raised against rat insulin and using rat insulin standards (25). Prior determination of the within-
assay coefficient of variation for 8 assays of pooled rat plasma was estimated at 6.2%.
Glucose and Lactate Analysis: Samples were analyzed in duplicate as is or diluted 1:10
with distilled water for glucose and lactate analysis using a YSI 2300 Stat Plus Analyzer (Yellow
Springs Instruments, Yellow Springs OH).
Amino Acid /Metabolite Assay: Analysis of nitrogenous metabolites were analyzed post-
hoc to probe an explanation for altered glucose and lactate data in Study A. There was
insufficient sample for amino acid analysis of Study B. The cell culture media (400µ1) was
prepared for analysis by precipitating protein from the samples with an equal amount of
sulfosalicylic acid solution (Pickering Seraprep) and centrifuging. The supernatant (300µ1) was
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aliquoted and an internal standard (Glucosaminic Acid, Sigma Chemical) was added. The
sample was filtered (0.2µm) and placed on the amino acid analyzer (Beckman 6300).
The Beckman System 6300 High Performance Amino Acid Analyzer uses ion exchange
chromatography with post-column ninhydrin reaction and visible colorimetric detection for the
analysis of amino acids. Depending on their dissociation characteristics, the amino acids are
differentially eluted from the column with a series of lithium buffers of increasing pH and ionic
strength, and further positioned by increasing the column temperature during the run. Ninhydrin,
mixed continuously with the column eluent, reacts in a highly specific manner with the separated
amines to form colored products, the intensity of which is proportional to the concentration of
the amino acid present.
Lactate Dehydrogenase (LDH) : LDH assays were performed in the supernatant of all
samples from Study B, using an in vitro toxicology assay (Sigma TOX-7, St. Louis, MO).
Statistical Analysis: There were multiple replications of the experimental protocol in
which two HARVs and two static plates were studied concurrently. In the initial studies, five
replications (islets from 12 pancreases) resulted in n=10 per experimental treatment group for
TNF-alpha, insulin, glucose, lactate analysis and amino acid analysis. Study B contained a subset
of n=4 different islet populations per group throughout. The experimental paradigm included
dependent variable analysis consisting of: A) basal TNF, insulin, glucose, lactate and nitrogenous
analytes during 48-hours of cell culture, and B) LPS .stimulation of TNF-alpha secretion,. and
subsequent insulin, glucose, and lactate measures during 48 hours of cell culture. The
independent variables used. for statistical analysis included: METHOD (HARV or static PLATE
culture), LPS (LPS stimulated, or non-LPS stimulated), and TIME (0, 48 hours for Study A; 0,
3, 6, 12, 24, 48 hours for Study B.
Study A, was analyzed by two-way (between I within) repeated measures analysis of
variance with interaction (GLM, METHOD vs TIME, SAS ver. 6.11, Cary NC, Snedecor and
Cochran 1989). Post-hoc differences between treatments within a time period, were determined
by a post-hoc Duncan's test. A value of p<0.05 was considered as statistically significant. Means
with similar superscripts are not significantly different by post-hoc analysis (p>0.05).
Study B, was analyzed by three factor (between I between I within) repeated measures
-6-
Manuscript: E-632-9-R
ANOVA (METHOD vs LPS vs TIME); main effects and interactions were determined. Raw
data was used for all analyses with the exception of the insulin data. Due to a twofold greater
basal insulin concentration in experiment 4, all data were transformed and normalized to %
baseline prior to statistical analysis. At discreet time points, a one-way between-subjects
analysis of variance was performed, and a post-hoc Duncan's test was used to determine
statistical significance between groups (p<0.05). Means with similar superscripts are not
significantly different by post-hoc analysis (p>0.05).
RESULTS
Pancreatectomy and Islet Isolation
Islets were isolated from living pancreas donors and were placed into cell culture within 5
hours following pancreatectomy. Five complete experiments were performed on separate islet
populations, with four treatment groups per experiment for Study A; a subset of four islet
populations per treatment were studied in Study B. There were no significant differences for the
150 micron islet equivalent mass in the islet populations between experimental groups (p>0.05,
Fig 1 b). The average number of islets per treatment group, was 1726±117 islet equivalent units.
All values as shown in figures are mean ± SEM.
LPS Stimulated-TGIF-alpha Production
Prior to LPS stimulation there were no significant differences in L929 TNF-alpha
cytotoxicity for any treatment group in any statistical measure (Fig 2a).
Following stimulation with LPS there were significant increases in TNF-alpha of both
static and HARV cultured cells (Fig 2b). Three-way repeated measures ANOVA indicated
significant between-subjects effects for METHOD (p=0.0049, static culture > HARV), LPS
(p=0.0001, LPS > non-LPS), and HARV*LPS (p =0.0046, static culture LPS > HARV LPS).
Within-subjects effects were significant for TIME (p=0.0001) and an interaction of
HOURS*LPS (p=0.0001). Islets stimulated with LPS in static culture retained a significantly
greater TNF-alpha concentration vs LPS stimulated HARV cultures throughout the entire 48
hours of the study. There were no significant changes in TNF-alpha among control cultures.
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Insulin Concentration
At time zero, insulin concentrations were less than 100 nmoles/l, and were not
significantly different between HARV and static culture treatment groups (Fig 3a). Repeated
measures ANOVA indicated a significant effect of TIME (p=0.0004, 48 HRS > 0 HRS).
Following 48 hours of culture, there was greater than a 3-fold increase in immunoreactive rat
insulin concentrations. However, there were no significant differences between HARV and static
cultures at 48 hours.
There was a marked linear increase in the insulin concentration of both HARV and static
culture islets which were not stimulated with LPS (Fig 3b). Repeated measures ANOVA
indicated no significant differences between-subjects; however, within-subjects effects of
HOURS and HOURS*LPS were significant (p=0.0001, p=0.0001). In both HARV and static
cultures which were stimulated with LPS, insulin secretion was attenuated relative to non-
stimulated treatment paradigms. At 48 hours post-stimulation with LPS, both control groups
were different from the HARV-LPS group. However, the static plate culture islets with LPS,
although intermediate in value at 48 HRS, did not differ from any other group in their insulin
content.
Glucose Concentration
Prior to cell culture, there were no significant differences in the amount of glucose in islet
medium between HARV or static culture groups (Fig 4a). Two-way repeated measures ANOVA
demonstrated a significant interaction of Time and Method (p=0.0488). The media from islets in
the PLATE culture had the lowest glucose concentration at 48 hours (p<0.05).
Following stimulation with LPS, there were relatively minor differences in the media
glucose concentration up to 12 hours of culture (Fig 4b). Repeated measures ANOVA indicated
a significant effect of METHOD (p=0.0203, HARV > static culture). The within-subjects effect
of HOURS was also significant (p=0.0026). At 48 hours post LPS stimulation, the static culture
group had metabolized the greatest amount of glucose from the media. The highest media
glucose concentrations were observed in the non LPS-stimulated HARV cultures, which were
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significantly different from the LPS stimulated static culture islets.
Lactate Concentration
Media lactate concentrations increased during the initial 48 hour culture period to a level
which was significantly different froin the zero hour value (Fig 5a). Repeated measures ANOVA
illustrated a significant effect of TIME (p=0.0001, 48 HRS > 0 HRS). However, there were no
significant differences between the lactate concentrations of HARV or static culture groups.
During the LPS stimulation studies, all treatment groups increased their lactate
concentrations (Fig 5b). Repeated measures ANOVA indicated a significant main effect only for
TIME (p=0.0001). At 48 hours of study, there were no significant differences between groups.
Amino Acid / Nitrot7enous Metabolite Concentrations
Amino acids and nitrogenous analytes were arranged into functional groupings and are
depicted in Table 1. Urea cycle metabolites of arginine and ornithine both demonstrated an
equimolar bidirectional shift in concentration favoring a greater difference in HARV
(TIME* METHOD, p=0.0027, 0.0001). Urea concentrations increased overtime( Within, Time,
p=0.0001) as did NH 3 which was equimolar in both HARV and PLATE (Within, "Time,
p=0.0001).
Nitrogen trans-fer -Igetabolites illustrated that glutamate , productior, and glutamme
utilization was equimolar in both HARV and PLATE (Within, Time, p=0.0001 for both).
Alanine concentrations increased in the islet media during the 48 hours of study (Within, Time,
p=0.0223).
Neurotransmitter synthesis metabolites of gamma-aminobutryric acid and
phosphatidylserine increased with time (Within, Time, p=0.0001). Glycine, an amino acid
associated with creatine, heme, and purine biosynthesis increased with time in both HARV and
PLATE (Within, TIME, p=0.0341).
Lactate Dehydro eg nase ( LDH)
There were no significant differences in LDH values at any time point in Study B (Table
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2). Repeated measures ANOVA with interaction determined significant between-subjects overall
effects of METHOD (HARV<PLATE, P=0.0505). Within-subjects analysis was significant for
TIME only (p=0.001).
HARV Generated Islet Cell Aggregates (ICAs)
Phase contrast microscopy of isolated islets of Langerhans cultured on static plates for
24-48 hours, illustrates intact islets with apparently intact collagen capsules, as well as soiree
freely circulating cells from islets which were over digested (Fig. 6a). Following forty-eight
hours of HARV culture, cellular aggregation is apparent as a ubiquitous phenomenon in ICAs
cultured in the microgravity model system (Fig. 6b). A prominent capsular appearance in the
periphery of the matrix of ICAs is apparent.
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DISCUSSION
The present studies were designed to investigate the influence of the HARV microgravity
model system and LPS administration upon 'FNF-alpha production of pancreatic islets of
Langerhans and elucidate related changes in insulin and glucose homeostasis. Studies were
designed to determine the independent influence of cell culture method and LPS stimulation
upon TNF-alpha activity and hormonal production, and elucidate potential interactions between
these variables. Additionally, investigation of nitrogenous analytes were performed to elucidate
all
	 for glucose and lactate data. The current studies demonstrate five novel
observations: 1) LPS induced TNF-alpha production is lesser in the HARV islet media, than in
static cultures, 2) the increase in TNF-alpha is associated with a lesser basal insulin secretion
especially in HARV cultures, 3) islets cultured with the HARV are associated with a lesser
glucose consumption, than are islets from static culture, 4) HARV islets demonstrate an
equimolar increase in the utilization of arginine and production of ornithine, and 5) islets
cultured with HARVs, will aggregate into "tissue like units", which we will designate as "Islet
Cell Aggregates" (ICAs).
A most interesting and novel result in our present study is that isolated islet preparations
in HARVs had increased TNF levels with exposure to LPS indicating that TNF-producing cells
are present in ICAs and that LPS stimulates TNF secretion in these islets. Our present studies
indicate-possible. involvement of TNF at the site of insulin, secretion, the, p9
—
t}creali i slets of rats.
Others have suggested that TNF gene expression may be located in the pancreas and may play a
role in islet function. Norman et al. (28) noted increased TNF messenger RNA expression and
intrapancreatic TNF detectable 1-6 hours after onset of acute pancreatitis induced by infusion of
a cholecystokinin analogue into mice. They attributed this TNF expression to acute infiltration
of macrophages during the pancreatic inflammation. Toyoda et al. (37) detected TNF-alpha in
mouse islets during development of diabetes in the non-obese diabetic mouse strain NOD-
Sansum. They noted that fewer than 1% of islet immune cells in this strain were macrophages
and suggested that TNF-alpha may be produced by islet T cells during an autoimmune reaction in
the islets of this diabetic mouse. Our data provides further evidence that islets can be sites of
TNF secretion in rats. We believe this is an intriguing observation with respect to islet secretory
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function. The lesser LPS induced TNF-alpha production in the HARV was not expected, and is
contrary to that which has been previously observed during in-flight studies of LPS stimulated
macrophages (6). The present investigations suggest three possibilities: 1) that islets behave
differently from macrophages following LPS stimulation in a microgravity model system, 2) that
results obtained in the HARV are not directly comparable to in-flight experiments, or 3) that the
aggregation of cells into ICAs differentially modulates the production of TNF-alpha, following
stimulation with LPS. The direct applicability of these data to in-flight studies remains to be
determined.
That TNF-alpha is associated with a decreased basal insulin secretion is intriguing, both
as it relates to in-flight extrapolations, ground based bed rest models, and as it suggests insight
into the pathophysiology of Type 1 and Type 2 diabetes mellitus. In-flight studies during the
Skylab mission (17) illustrated a consistent decrease in the plasma insulin concentration from 38
to 82 days. A decrease in pancreatic insulin secretion is seen both following autoimmune insulitis
of type 1 diabetes (10) and following prolonged peripheral insulin resistance with compensatory
pancreatic-derived hyperinsulinemia in type 2 diabetes (39). It is not possible to say if these
data are comparable, as serum insulin values are affected by rates of insulin secretion, insulin
sensitivity, and insulin clearance: factors which were not measured on Skylab. In addition,
plasma glucose values were also decreased in Skylab crewmembers, suggesting improved
glucose control. -However, the Skylab data have been viewed as conflicting; since a sharp drop in
insulin was followed with a trend towards an increase, which was subsequently followed weeks
later by a spike in insulin during the third and forth weeks of flight (26). This could occur if
there were a compensatory increase in insulin production secondary to reduced insulin sensitivity
as suggested by Stein (33); however, this would have to occur in a time-dependent process with
pancreatic function reacting secondarily and/or primarily to spaceflight stressors. The present
studies raise the possibility of an endogenously mediated decrease in insulin secretion, as a
secondary consequence of altered cytokine production in the HARV microgravity model system.
That a lowest basal insulin secretion was observed in LPS stimulated HARV cultures, is a novel
observation, and suggests that islet derived TNF has a potent capacity to down regulate islet
insulin secretion in microgravity model systems. We hypothesize that this reduction in insulin
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secretion occurs at a lower media concentration of TNF-alpha in the HARV, than is observed in
the static plate controls, possibly due to higher intracellular concentrations of TNF in the ICAs.
This hypothesis is currently under investigation in ongoing studies.
Ground based-bed rest studies support the hypothesis of a progressive increase in insulin
resistance, which is accompanied by a decrease in muscle mass following prolong physical
inactivity (4). TNF has not been related to this effect, but has been suggested as a mechanism of
obesity induced insulin resistance, which may accompany decreased activity levels (1, 14).
Others have suggested that TNF may play a direct role in islet cell function during the
autoimmune response in the development of insulin-dependent diabetes mellitus. Duager et al.
(9) found that direct TNF exposure inhibited insulin secretion and caused significant DNA strand
breakage in isolated rat islets. Others reported that TNF attenuated islet cell function and
proposed that direct stimulation by TNF may be involved in modulation of insulin secretion from
alpha cells during the progressive autoimmune development of insulin-dependent diabetes
mellitus. The pathophysiology of Type 2 diabetes mellitus is known to involve a decrease in
insulin sensitivity, an initial compensatory hyperinsulinemia, followed by a subsequent decline
in pancreatic insulin secretion (7). When sequentially combined, these events promulgate
hyperglycemia. The influence of TNF-alpha in peripheral insulin resistance of adipose tissue has
been implicated in the pathophysiology of Type 2 diabetes (13, 14). The present studies provide
an additionaL_,nlechanism by which islet derived TNF-alpha m contribute to the development
of Type 2 diabetes by suppressing insulin secretion and promulgating hyperglycemia. The
clinical relevance of these observations is unknown. The consistent increase in media insulin
concentration, and the similar LDH activity of all groups, demonstrates two measures of cell
viability throughout the study.
It has been proposed that insulitis with inflammatory cell influx into islets is responsible
for any islet expression of TNF which may then influence islet function. While macrophages are
present in islets and may be producing TNF in response to LPS, we propose that other possible
sites of TNF production may also exist in the islet infrastructure. The many endocrine cell types
located in islets could be possible sources of TNF, but vascular smooth muscle cells of the
complex intra-islet vasculature may also be secreting TNF. In previous studies (27), we have
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shown that human blood vessels can be a significant source of TNF. We found that when
stimulated with LPS, the time-dependant release of TNF from human vascular tissue was
significantly increased compared with time-matched non-stimulated control vascular tissue. In
human smooth muscle cells cultured from both internal mammary arteries and saphenous veins,
the release of'INF into the medium essentially mimicked that seen in the intact vascular
segments. Our experiments showed that TNF release occurred from both intact blood vessels and
smooth muscle cells. Collectively, these findings suggested that at least one source of TNF may
be the smooth muscle cell within vascular tissue. Since all islets have afferent arterioles that
branch into numerous capillaries to form glomerular-like structures Vdiiell then form an extensive
network of peri-insular collecting venules, it is an intriguing possibility that cells, other than
macrophages, located in or near such highly vascularized islet beds may also synthesize and
secrete TNF. Preliminary immunoliistochemical studies (data not shown) illustrate that TNF-
alpha is present in the cytosol of endothelial cells of the islet vasculature, and the cytosol of islet
endocrine cells following LPS stimulation; TNF-alpha is not present in exocrine tissue. Thus,
the exact sites of TNF-alpha gene transcription and translation remains to be delineated in future
studies.
The present studies demonstrated alterations in disappearance of glucose and arginine,
and differences in appearance of ornithine as a result time and the cell culture method used. The
lack of a change in,media glucose ,concentration of HARV cultures during _hours .of Study A,
and 48 hours of LPS culture in Study B, suggests that alternative fuel sources have been utilized
or that basal energy expenditure was significantly reduced in the microgravity model system.
The equivalent values in lactate concentration between groups over time indicate this
phenomenon is not explained by altered glycolytic activity. In the basal state 30% of islet
metabolic energy requirements are met by the oxidation of the amino acid glutamine (23).
Glutamine is the most abundant amino acid in the body and plays a primary role as a carrier of
nitrogen between organs, with it's amide group used for nucleic acid biosynthesis (41). We
added 0.68 mmoles/I L-glutamine to the Medium-199 utilized in the present studies, an amount
sufficient to support basal energy expenditure. The nitrogenous compounds analyzed in the
current experiments illustrate that glutamine is used ubiquitously by islets of Langerhans,
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regardless of the experimental paradigm. The equimolar increase in alanine in HARV islets is
consistent with the concept of an increased utilization of glutamine for energy by the splanchnic
organs, in times of catabolic stress. However, arginine disappearance and ornithine appearance
coexist with a 2x greater change in urea concentrations in HARVs. Taken together, these
observations suggest increased arginase activity in HARV cultured islets of Langerhans. Since
insulin was not altered in Study A, we hypothesize that the decrease in arginine concentration
observed in the present studies was not sufficient to alter basal insulin secretion. However, if
there were an increase in insulin resistance during spaceflight which was present during the
postprandial state, an increased conversion of arginine to ornithine may modulate a decreased
ability for compensatory insulin secretion. The lack of a significant increase in the amino acid
citrulline, rules out a more active nitric oxide synthase vs arginase. Thus, nitric oxide production
via arginine to citrulline conversion, is likely not greater in the HARV, and islet blood perfusion,
vascular reactivity, or membrane integrity is in all likelihood not compromised. The equimolar
increase in urea, however, would suggest that an increase in total urea cycle activity is not a
plausible explanation for these data. Decreases in lean body mass, and altered amino acid
utilization illustrate that nitrogenous metabolites are influenced by spaceflight (34-36). In
ground-based studies, the reduction in lean body mass occurs concomitantly with altered glucose
and insulin metabolism (21, 22, 29). At present there is no unified hypothesis to explain these
observations, although it has been .suggested-that a_loss of lean_bo_dy-tnass and - subsequent release
of nitrogenous metabolites, may be related to an increase in insulin resistance (33). The present
a ... studies are the first to document decreased glucose utilization, concomitant with alterations in
nitrogenous analyte utilization, respective to an in vitro microgravity model system, and thus,
both support and extend the data and hypotheses of Stein (33-36).
The aggregation of isolated islets of Langerhans into ICAs was a serendipitous discovery.
From the four experiments conducted herein, we observed that islet aggregation occurs within 15
hours of HARV culture. That cells will aggregate within the HARV is a well known
phenomenon, and has been documented elegantly in a recent review (38). Islet transplantation
research currently underway which utilizes a microgravity model system for cell assernbly, is
aimed at developing an islet beta cell / sertoli cell aggregate for transplantation in Type 1
-15-
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diabetes (5). The present studies illustrate that approximately 1700 whole islets will aggregate
into WAS that measure approximately 3 mm in diameter. The importance of such a large tissue
mass may be salient to the success of pancreatic islet transplantation as a cure for Type 1 diabetes
mellitus. At present, purified islets of Langerhans have been transplanted intraportally into the
liver of Type 1 patients, resulting in normalization of plasma glucose concentrations (40). The
requirement for immunosuppresion is contraindicated to effective islet function, as most
immunosuppresive agents decrease insulin sensitivity. Sertoli-islet cell aggregates may provide
an immunoproviledged graft. However, these cells %vill still need to be transplanted into a highly
vascularized organ site such as the liver. The potential of ICAs lies in the possibility of creating
a greater tissue mass, with potential vascularization, which can be transplanted into a readily
accessible vascularized organ such as the kidney capsule. Such an approach, if combined with
sertoli cell technology, would provide a graft that is in1n111nopriviledged and allow for removal of
the graft in the presence of rejection. Such options are not currently available for intraportal islet
transplants, and at present, recipients of purified islets require lifelong 1 111 111 11 1 1 0SUppreslon. SUCK
possibilities are encouraging for ultimate success in the search for a cure for Type 1 diabetes; a
cure which ideally will ameliorate the need for daily exogenous insulin administration, and
prevent the devastating secondary complications of this disease.
In conclusion, the present studies demonstrated alterations in LPS induced TNF-alpha
production of pancreatic islets of Langerhans, favoring  lesser .TNF-production in the
microgravity model system HARV paradigm. We conclude that rat pancreatic islets are possible
sources of TNF during exposure to bacterial LPS and that insulin secretion may be altered by
LPS-induced TNF secretion. Our results are most interesting since TNF has been implicated as
possibly playing a significant role in the obesity-related development of insulin resistance,
glucose intolerance and non-insulin-dependent diabetes mellitus. If one proposes that an
infectious agent or even increased levels of circulating lipoprotein or glucose could stimulate
TNF secretion within the islet which then may alter insulin secretion, intriguing hypotheses could
be developed as to the local production of islet-derived TNF and its action on islet cell function
in the whole body. The present studies also illustrated that basal insulin secretion was suppressed
concomitant with an increase in TNF-alpha, and may be implicated in hormonal alterations of
-16-
Manuscript: E-632-9-R
spaceflight and the pathophysiology of Type 2 diabetes. Fuel homeostasis appears to be different
in the HARV culture, as virtually no glucose was utilized in this paradigm, suggesting an
alternative fuel source for ICAs. While nitrogenous compound analysis indicated a ubiquitous
reliance upon glutamine in all experimental groups, argimne was converted to ornithine at a two-
fold greater rate in the islets cultured in the HARV microgravity model system. Such
-observations su est cell -specificecific effects of this s stem upon nitrocompound utilization. nitrogen us comgg	 p	 Y	 P	 g	 P
Finally, islets which are cultured in HARVs will aggregate into ICAs. A limited number of
biochemical and physiological characteristics of these aggregates have been documented in the
present studies. The clinical significance of these observations to the pathophysiology of
diabetes or their relation to manned space flight, however, remains to be determined.
-17-
Manuscript: E-632-9-R
ACKNOWLEDGMENTS
The authors would like to acknowledge the important advice and assistance of Dr. Neal
Pellis and Dr. Judith Campell-Washington (NASA-JSC) for discussing microgravity model
systems with the authors, and advocating the HARV system as appropriate for these studies. Dr.
Diana Risen (NASA-JSC) gave timely advice, technical support and guidance in the use of
14ARV techniques for cell culture work. Dr. Peter Farrell, Professor of Physiology at The
Pennsylvania State University, was most helpful in sharing his personal expertise and
unpublished data on islet secretory function in free fall and microgravity model systems.
Without the gracious interdisciplinary assistance of these individuals at several institutions, these
studies would not have been carried to successful completion.
Kimberly Welch-Holland, MUSM laboratory research technician, performed analysis of
insulin, glucose and lactate in islet medium. Myra D. Smith, NASA-JSC performed analysis of
nitrogenous compounds. These studies were supported by a Summer Faculty Fellowship from
the American Society for Engineering Education and NASA, a NASA-JSC Director's Grant
(NAG 9-1021), and the Robert W. Hansen Diabetes Fund of the Fraternal Order of Eagles.
-18-
Manuscript: E-632-9-R
REFERENCES
1. Argiles, J.J., J. Lopez-Soriano and F. Lopez-Soriano. The role of cytokines in diabetes:
update 1994. Edocrin. Rev. 2:76-80, 1994.
2. Armstrong, J.W., R.A. Gerren and S.K. Chapes. The effect of space and parabolic flight on
macrophage hematopoiesis and function. Exp. Cell. Res. 216:160-168, 1995.
3. Ballinger, W.F and P.E. Lacey. Transplantation of intact pancreatic islets in rats. Surgery
72:175-186, 1972.
4. Berg, H.E., and Tesch, P.A. Changes in muscle function in response to 10 days of lower limb
unloading in humans. Acta Physiol. Scand. 157:63-70, 1996.
5. Cameron, D.F., Selawry, H.P., Heller, R. and J. Becker. Development of an insulin secreting,
iminunopriviledged cell-cell aggregate utilizing the NASA rotating wall vessel. NASA MRD
Program Task - Ground Based, 1998.
I
6. Chapes; S -K.; et al. Cytokine secretion_by immune.cells in space..- I-Leukocc_yt^^. Biol.
52:104-110, 1992.
7. DeFronzo, R.A., D. Simonson and E. Ferrannini. Hepatic and peripheral insulin resistance: a
common feature of Type 2 and Type 1 diabetes mellitus. Diabetologia 23:313-319, 1982.
8. Dolkas, C.B. and J.E. Greenleaf. Insulin and glucose responses during bed rest with isotonic
and isometric exercise. J. Appl. Physiol. 43:1033-1038, 1977.
9. Dunger, A., J.M. Cunningham, C.A. Delaney, J.E. Lowe, M.H.L. Green, A.J. Bone, and I.C.
Green. Tumor necrosis factor-alpha and gamma interferon inhibit insulin secretion and cause
-19-
Manuscript: Z-632-9-R
DNA damage in unweaned-rat islets. Diabetes 45:183-189, 1996.
10. Eisenbarth, G.S., Connelly, J., Soeldner, J.S. The "natural" history of Type I diabetes.
Diabetes/Metabolism Revs. 3:873-891, 1987.
11. Finegood, D.T., B.W. Tobin and J.T. Lewis. Dynamics of glyceinic normalization following
islet transplantation with sub-optimal islet mass. Transplantation 53:1033-1037, 1992.
12. Grigoriev, A.J. Man in space flight. Presentation at the 3" Nihon University International
Symposium on Aerospace Science. Tokyo, Japan, 1990.
13. Hotamisligil, G.S. and B.M. Spiegelman. Tumor necrosis factor alpha: a key component of
the obesity-diabetes link. Diabetes 43:1271-1278, 1994.
14. Hotamisligil, G.S., A. Budavari, D. Murray and B.M. Spiegelman. Reduced tyrosine kinase
activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J.
"	 Clin. Invest. 94:1543-1549, 1994.
15. Hughes-Fulford, M. and M.L. Lewis: Effects of microgravity on osteoblast growth.
activation. Exp. Cell. Res. 224:103-109, 1996.
16. Kahn S.E., R.L. Prigeon, D.K. McCulloch et al. Quantification of the relationship between
insulin sensitivity and B-cell function in human subjects. Evidence for a hyperbolic function.
Diabetes 42:1663-1672,1993.
17. Leach, C.S. and P.C. Rambaut. Biochemical responses of the Skylab crewman: an overview.
In: Biomedical Results from Skylab. NASA Lyndon B. Johnson Space Center. Johnson, R.S..
and L.F. Dietlein. Scientific and Technical Information Office. National Aeronautics and Space
Administration. Washington D.C., 1977.
-20-
nManuscript: E 632-9-R
18. Leeper-Woodford, S.K., D. Carey, K. Byrne, B. Fisher, C. Blocher, H. Sugerman and A.
Fowler. Ibuprofen attenuates plasma tumor necrosis factor activity during sepsis-induced acute
lung injury. J. Appl. Physiol. 71:915-923, 1991.
19. Leeper-Woodford, S.K., B. Fisher, H. Sugerman and A. Fowler. Pharmacologic reduction
in tumor necrosis factor activity of pulmonary alveolar macrophages. Am. J. Respir. Cell Mol.
Biol. 8:169-175, 1993.
20. Leeper-Woodford, S.K. and B.W. Tobin. Tumor necrosis factor activity of pancreatic islets.
Am. J. Physiol 273:E433-E437, 1997.
21. Lipman, R.L. et al. Glucose intolerance during decreased physical activity in man. Diabetes
21:101-107, 1972.
22. Lipman R.L., F. Ulvedal, J.J. Schnure, E.M. Bradley and F.R. Lecocq. Gluco-regulatory
hormone response to 2-deoxy-d-glucose infusion in normal subjects at bedrest. Metabolism
19:980-987, 1970.
23. Malaisse W.J., A. Sener, A.R. Carpinella et al. The stimulus-secretion coupling of glucose
induced insulin release. XLVI: Physiologic role of 1-glutamine as a fuel for pancreatic islets.
Mol. Cell Endocrinol. 20:171-189, 1980.
24. Maap. H., W. Raabe and H.M. Wegman. Effects of microgravity on glucose tolerance.
Proceedings of the Norderney Symposium on Scientific Results of the German Spacelab Mission
D-2, March 14-16,1994, Norderney, Germany.
25. Morgan, C.R. and A. Lazarow. Immunoassay of insulin: Two antibody system. Plasma
insulin levels in normal, subdiabetic, and diabetic rats. Diabetes 12:115, 1963.
-21-
rManuscript: E-632-9-R
26. National Academy of Sciences. Endocrinology. In: A Strategy for Research in Space Biology and
Medicine in the New Century. National Academy Press. Washington, D.C. 1998.
27. Newman, W.H., L. Zllang, S.K. Leeper-Woodford, and M.R. Castresana. Human blood
vessels release tumor necrosis factor-alpha from a smooth muscle cell source. Crit. Care. Med.
24:294-297, 1996.
28. Norman, J.G., G.W. Fink, and M.G. Franz. Acute pancreatitis induces intrapancreatic tumor
necrosis factor gene expression. Arch. Sti ng. 130:966-970, 1995.
29. Piemme T.E. Effects of two weeks of bed rest on carbohydrate metabolism. ln: Proceedings
of the NASA Symposium: Hyopogravity and Hypodynamic Environments. June 16-18, 1969, Pg
281-287.
30. Ricordi, C. et al. Islet isolation assessment in man and large animals. Acta. Diabetol. Lat.
27:185-195, 1990.
31. Schwarz, R.P., Goodwin, T.J. and D.A. Wolf. Cell culture for three dimensional modeling
in rotating-.Wall-.vessels: an application to simulated microgravity. J. Tiss. Culture Meth. 14:51-
58, 1992.
32. Sonnenfeld, G., C.L. Gould, J. Williams and A.D. Mandel. Inhibited interferon production
after space flight. Acta Microbiol. Hung. 35:411-416, 1988.
33. Stein T.P., M.D. Schulter and G. Boden. Development of insulin resistance by astronauts
during spaceflight. Aviat Space Environ Med 65:1091-1096, 1994.
34. Stein T.P., M.J. Leskiw and M.D. Schluter. Diet and nitrogen metabolism during spaceflight
on the shuttle. J. Appl. Physiol. 81:82-97, 1996.
-22-
rManuscript: E-632-9-R
35. Stein T.P., M.J. Leskew, M.D. Schluter, M.R. Donaldson and 1. Larina. Protein kinetics
during and after long-duration spaceflight on MIR. Am, J. Physiol. 276:E1014-E1021, 1999.
36. Stein T.P. and M.D. Schluter. Plasma Amino Acids during human spaceflight Aviat.. Space
Environ. Med. 70:250-255, 1999.
37. Toyoda, H., B. Formby, D. Magalong, A. Redford, E. Chan, and M.A. Charles. In situ islet
cytokine gene expression during development of type I diabetes in the non-obese diabetic mouse.
Inununol. Letters 39:283-288, 1994.
38. Unsworth, B.R. and P.I. Lelkes. Growing tissues in microgravity. Nature Medicine 4:901-
907, 1998.
39. Ward, W.K., J.C. Beard and D. Porte Jr. Clinical aspects of islet b-cell function in 11011-
insulin dependent diabetes mellitus Diabetes/Metabolism Revs. 2:297-313, 1986.
40. Warnock, G.L., N.M. Kneteman, E.A. Ryan, A. Rabinovitch, and R.V. Rajotte. Long-term
follow-up after transplantation of insulin-producing pancreatic islets into patients with Type 1
(insulin dependent) diabetes mellitus. Diabetologia 35:89-95; 1992: 	 r .^
41. Windmueller H.GT. Glutamine utilization by the small intestine. Adv. Enzymol. 53:201-
237, 1982.
42. Yki-Jarvinen H., and V.I. Koivisto VA. Natural course of insulin resistance in Type I
diabetes. N. Engl. J. Med. 315:224- 231, 1986.
-23-
q
*
p
W
o
L U
xE
oo
o
c
n
c
n
c
n
c
n
c
n
c
n
C/)
Y
	
W
o
o
Z
Z
Z
Z
Z
Z
z
2
U
 o
Q
^
o
 H
 c
>
3
0
i^,
o
o
v
i ^?
O^
-
W
oO
0O
O
0O
V'
oO
N
O
OO
MO
UC
0
¢
,^^-^
OO
OO
OO
OO
OO
OO
OO
OO
O
O
a
s
a
r
-
 
q
c
n
o
c
n
c
n
c
n
c
n
c
n
c
n
c
n
c
n
¢
as
0
0
z
o
z
z
z
z
z
z
z
z
3
N
 Q
LLI
L
4
a7
	
x
c
n
c
n
c
n
c
n
c
n
c
n
c
n
z
c
n
z
c
n
z
c
n
z
b
o
z
z
z
z
z
z
O
f
	
¢N
;
C
 f
CAO
D1CO
NN
^p
VlcD
N
•--
00viO
\-C,OO
MOrn
IL--"
¢
 W
0
0
0
0
0
0
CA0
0
0
0
°-
	
a
0
0
0
0
0
o
O
O
o
^
¢
z
O
O
¢
WE
-¢
00v°.
Crlo.
^
^°.
o
V0
0
M0
M0
C
/) U
oo
O
o
0
0
0
0
0
0
0
-
	
Z
V;
^
u
^
r
N
CND1
¢
^
¢
J°
O
N
V
[^
N
O
o
0
0
0
0
CD
o
o
°
z
x
O
O
O
o
z
	
rr
Q
 W
 G
H
Cl)O
-H
O
N
00cn
.
_
 
¢
 
rn
>
O
D1
Ul
O
N
7
r
C11
Q
o
0
0
0
0
0
O
o
q
-
WT
-0
00
.
-
-
.
N
0
0
V
CN
M
td
	
,^
N
O
N
^
_
N
oM
O
—O
M
O
	
T
O
O
Oo
O0
O0
O0
O0
O0
O0
O0
3 Wa
O+i
O+i
+1
-H
-H
-H
+i
+I
-H
+I
¢
W(--
^
vNi
00V')
00Cl)
^DN
[v^'i
00^
MC\N
MN-
00
O
O
 cn
Q
C,N
c-O
OV
Nc
n
00O,
v'i'IC!
M
O
O
U-
O
 
>
+
a
.
o
o
O
o
0
0
0
0
0
0
>
°
 vU
x
lW^
OW')
4\M
Q\[^
110'^
U00
Cl)
V')
c1
cd ¢
O
O
O
O
O
O
O
O
O
O
U
¢
O
O
O
O
O
O
O
O
O
O
O bi
R
V
-H
O^.--^
ON
c^
VV
00oo
.
L
	
01)  .--.
NN
rN
v^
[^M
O
'o
^
O
O
00
N
 
V
l
00
	
O
¢x
o
0
o
O
-
O
o
0
0
0
arnZ
q .-: a^iL
Lsao
O\
^p
N
M
V'
N
(-
00
1
 b
_
N
V'O
NM
O-
-^
^--^
I^
[M^
OM^
-
-
'
O
c
-
O
M^fO
L
 
vi T
>
OO
OO
OO
OO
OO
OO
OO
OO
OO
O
LO
 U
W
N
-H
W)
^
m
O
N
W
id W
 C
f-'Q`
•--
M
^pN
^pCl)
^!1V7
•^M
coN
MO\
^OO
UO
^OV'
00
0
0
0
0
0
0
0
oo
	
o
a
o
0
0
v
^
	
C
L
OV
-)
r-.
N
NQ\
M[^
^O
uJ
o0-
00
hpJ
a? >
x
ON
OO
NO
OO
V7O
NO
MM
OO
OO
MO
.^
 („U
	
O
O (—,
O
O
O
O
O
O
O
O
O
O
j 0
Q` W
+
1
+i
0
0
+
i
0
0
+
+
-p
	
4
1
t
i
 
0
0
+
+
4
1
+i
V
+
1
110
-
H
Q
 
O
L
o
	
a
o
cy
x
°
 0
0
0
0
0
0
0
o
o
C/I>
t
i
^
+1 C4 UU
 N
N
 ¢
h`.
^
W
^^^,
Q
E
 q
	
a
,
.
.
.
^
 p
C
of ^.,
^
 O
V
N
x
to
 .a
.a
a
o
 Q
cn
W
v
W
 
Q
Qcc^
JV
C
	
v
N
 _
 v
^
 
o
1
 
1
v
 
.
^
tiC
	
^^UdohUtiO
f
0OwdUOvONON0tic^
c
^i
Manuscript: E-632-9-R
Table 2. Lactate Dehydrogenase activity (LDH) measured during 48 hours of cell culture in HARV
and Static Plates, with and without LPS stimulation.
Hours Post LPS Stimulation
0 3 6 12 24 48
HARV-CN 0.14±0.11 0.12±0.01 0.14±0.01 0.12f0.01 0.15t0.02 0.14±0.01
HARV-LPS 0.14±0.01 0.13±0.02 0.13±0.02 0.12±0.01 0.16±0.02 0.13±0.02
PLATE-CN 0.15±0.01 0.14±0.02 0.15±0.01 0.14±0.01 0.17±0.02 0.15±0.01
PLATE-LPS 0.16±0.01 0.17±0.01 0.16±0.01 0.13±0.00 0.23±0.02 0.14±0.01
Data are means ±SEM for 3 separate islet populations per mean. Between-subjects ANOVA indicated
no differences between groups, at any time point (p>0.05). Overall experiment analysis with all time
points considered indicated less LDH in HARV vs. PLATE cultures (p=0.0505). Within-subjects
effects were significant only for TIME (p=0.001).
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Study:	 A --	 B	 -
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Day:	 1	 2	 3	 4	 5	 6	 7
Protocol:	 Islets-Isolated-	 Basat-Studie-s	 TNEStudies.
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FIGURE 1. The experimental design (I a) and the islet equivalent units per treatment group (I b).
HRV-CN, HARV control; HRV-LPS, HARV LPS-stimulated; PLT-CN, static culture plate control;
PLT-LPS, static culture plate stimulated with LPS. Data are means ±SEM.
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FIGURE 2. TNF -alpha in islet medium: a) during 48 hours culture, b) post LPS stimulation,
HRV-CN, HARV control; HRV-LPS, HARV LPS-stimulated; PLT-CN, static culture plate control;
PLT-LPS, static culture plate stimulated with LPS. Data are means ±SEM. There were no significant
differences in L929 TNF-alpha cytotoxicity for any treatment group Study A. Following stimulation
with LPS there were significant increases in TNF-alpha (Study B). Significant between-subjects
effects were noted for METHOD (p=0.0049, static culture > HARV), LPS (p=0.0001, LPS > non-
LPS), and HARV*LPS (p=0.0046, static culture LPS > HARV LPS). Within-subjects effects were
significant for TIME (p=0.0001) and interaction of HOURS*LPS (p=0.0001).
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FIGURE 3. Insulin in islet medium: a) during 48 hours culture, b) post LPS stimulation. I-IRV-CN,
HARV control; HRV-LPS, HARV LPS-stimulated; PLT-CN, static culture plate control; PLT-LPS,
static culture plate stimulated with LPS. Data are means ±SEM. At time zero, insulin values were not
different in Study A, however, ANOVA indicated a significant effect of TIME (p=0.0004). In Study
B, insulin concentration increased in both HARV and static culture islets not stimulated with LPS.
There were no significant differences between-subjects; however, within-subjects effects of HOURS
and HOURS*LPS were significant (p=0.0001, p=0.0001). In both LPS-stimulated cultures insulin
secretion was less compared to controls. At 48 hours both control groups were different from the
HARV-LPS group; the static plate culture islets with LPS was intermediate in insulin content.
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FIGURE 4. Glucose in islet medium: a) during 48 hours culture, b) post LPS stimulation. HRV-CN,
HARV control; HRV-LPS, HARV LPS-stimulated; PLT-CN, static culture plate control; PLT-LPS,
static culture plate stimulated with LPS. Data are means ±SEM. At time zero, there were no
significant differences in the glucose concentration in islet medium in Study A; however, following
48 hours, there was a significant interaction of Time and Method (p=0.0488). The media from islets in
the PLATE culture had the lowest glucose concentration at 48 hours (p<0.05). In Study B, there were
minor differences in the media glucose concentration up to 12 hours of culture. ANOVA indicated a
significant effect of METHOD (p=0.0203, HARV > static culture) and HOURS (p=0.0026). At 48
hours post LPS stimulation, the static culture group had metabolized the greatest amount of glucose
from the media. The highest media glucose concentrations were observed M the non LPS-stimulated
HARV cultures, which were significantly different from the LPS stimulated static culture islets.
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FIGURE 5. Lactate in islet medium: a) during 48 hours culture, b) post LPS stimulation. HRV-CN,
HARV control; HRV-LPS, HARV LPS-stimulated; PLT-CN, static culture plate control; PLT-LPS,
static culture plate stimulated with LPS. Data are means ±SEM. The 48 hour value was significantly
different from the zero hour value as the repeated measures ANOVA illustrated a significant effect of
TIME in Study A (p=0.0001, 48 HRS > 0 HRS). During LPS stimulation (Study B) all treatment
groups increased their lactate concentrations; ANOVA main effects were significant only for TIME
(p=0.0001).
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a
b
a
FIGURE 6. Phase-contrast photomicrographs of freshly isolated islets of Langerhans from male
Wistar Furth rats (6a), and islets cultured for 48 hours in the HARV (6b). All images were obtained
using a 40x air objective with a green filter and white fiber optic side illumination..
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